QUINJA Trademark

Trademark Overview

On Friday, July 1, 2016, a trademark application was filed for QUINJA with the United States Patent and Trademark Office. The USPTO has given the QUINJA trademark a serial number of 87091261. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 21, 2025. This trademark is owned by Novum Pharma, LLC. The QUINJA trademark is filed in the Pharmaceutical Products category with the following description:

Medicated topical prescription preparation for antifungal, antibacterial and anti-infective uses
quinja

General Information

Serial Number87091261
Word MarkQUINJA
Filing DateFriday, July 1, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 21, 2025
Registration Number5561594
Registration DateTuesday, September 11, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2016

Trademark Statements

Goods and ServicesMedicated topical prescription preparation for antifungal, antibacterial and anti-infective uses

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 21, 2025
Primary Code005
First Use Anywhere DateFriday, May 18, 2018
First Use In Commerce DateFriday, May 18, 2018

Trademark Owner History

Party NameNovum Pharma, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60654
Party NameNovum Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60654
Party NameNovum Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressChicago, IL 60654

Trademark Events

Event DateEvent Description
Tuesday, July 5, 2016NEW APPLICATION ENTERED
Wednesday, July 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 30, 2016TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED
Thursday, October 6, 2016ASSIGNED TO PETITION STAFF
Thursday, October 6, 2016PETITION TO DIRECTOR - MAKE SPECIAL - GRANTED
Thursday, October 6, 2016ASSIGNED TO EXAMINER
Monday, October 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 26, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 15, 2016PUBLISHED FOR OPPOSITION
Tuesday, November 15, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 14, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, January 13, 2017OPPOSITION INSTITUTED NO. 999999
Tuesday, May 23, 2017OPPOSITION TERMINATED NO. 999999
Tuesday, May 23, 2017OPPOSITION DISMISSED NO. 999999
Tuesday, May 23, 2017ABANDONMENT - AFTER INTER PARTES DECISION
Tuesday, May 23, 2017REINSTATEMENT GRANTED - TTAB DECISION REVERSED
Tuesday, July 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 9, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 22, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, November 22, 2017SOU EXTENSION 1 FILED
Wednesday, November 22, 2017SOU EXTENSION 1 GRANTED
Friday, November 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 26, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, June 26, 2018USE AMENDMENT FILED
Wednesday, July 18, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 18, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 8, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 9, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 11, 2018REGISTERED-PRINCIPAL REGISTER
Monday, September 11, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 21, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

quinja anti infective uses antibacterial antifungal topical prescription preparation medicated